Mode
Text Size
Log in / Sign up
N/A N=84 Randomized Treatment

Stroke Rehabilitation Using Brain-Computer Interface (BCI) Technology

Stroke

Enrolled (actual)
84
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Action Research Arm Test Scores — 28.10; 27.76; 29.95; 30.18 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Functional Electric Stimulation (FES) (Device); Behavioral Assessments (Behavioral); Magnetic Resonance Imaging (Other); EEG (Other)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
University of Wisconsin, Madison
Primary completion
Dec 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Action Research Arm Test Scores
28.10; 27.76; 29.95; 30.18; 32.53; 32.83
PRIMARY
Stroke Impact Scale
61.90; 66.07; 70.29; 68.22; 69.97; 67.35
SECONDARY
Change in Electroencephalogram (EEG) Response Strength
1.120; 0.882; 0.855; 1.145; 0.970; 1.236
SECONDARY
Signal Change in Functional Magnetic Resonance Imaging (MRI)
1.136; 1.203; 1.003; 1.153; 1.130; 1.108
SECONDARY
Nine Hole Peg Test (9HPT)
59.89; 59.07; 59.53; 59.24; 59.65; 58.52
SECONDARY
Motor Activity Log (MAL): Amount of Use
0.9888; 1.280; 1.052; 1.452; 1.413; 1.750
SECONDARY
Motor Activity Log (MAL): Quality of Movement
0.9564; 1.219; 1.073; 1.372; 1.363; 1.846
SECONDARY
Change in Modified Ashworth Scale (MAS)
SECONDARY
Hand Grip Strength
32.95; 31.54; 32.86; 31.10; 34.66; 34.78
SECONDARY
Center for Epidemiologic Studies Depression Scale (CES-D)

Summary

The purpose of this research is to determine if functional muscle stimulation, directed by electroencephalogram (EEG) output, can increase the extent of stroke recovery on behavioral measures and induce brain plasticity as measured by functional magnetic resonance imaging (fMRI). Participants will include stroke patients with upper-limb hemiparesis and can expect to be on study for approximately 4 months.

Eligibility Criteria

Inclusion Criteria

  • New-onset ischemic stroke 12 months prior - chronic time frame;
  • Right hand dominant - affected arm;
  • Mild to moderate unilateral upper extremity impairment or severe unilateral upper extremity impairment;
  • No upper extremity injury or conditions that limited use prior to the stroke;
  • Must be able to provide informed consent on their own behalf.

Exclusion Criteria

  • Inability to competently participate in study procedures
  • Concurrent upper extremity therapy, other neurological or psychiatric disorders
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04141774). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search